Insurance Coverage Criteria for Bariatric Surgery: A Survey of Policies.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 22 11 2019
medline: 2 4 2021
entrez: 22 11 2019
Statut: ppublish

Résumé

Bariatric surgery remains underutilized at a national scale, and insurance company reimbursement is an important determinant of access to these procedures. We examined the current state of coverage criteria for bariatric surgery set by private insurance companies. We surveyed medical policies of the 64 highest market share health insurance providers in the USA. ASMBS guidelines and the CMS criteria for pre-bariatric evaluation were used to collect private insurer coverage criteria, which included procedures covered, age, BMI, co-morbidities, medical weight management program (MWM), psychosocial evaluation, and a center of excellence designation. We derive a comprehensive checklist for pre-bariatric patient evaluation. Sixty-one companies (95%) had defined pre-authorization policies. All policies covered the RYGB, and 57 (93%) covered the LAGB or the SG. Procedures had coverage limited to center of excellence in 43% of policies (n = 26). A total of 92% required a BMI of 40 or above or of 35 or above with a co-morbidity; however, 43% (n = 23) of policies covering adolescents (n = 36) had a higher BMI requirement of 40 or above with a co-morbidity. Additional evaluation was required in the majority of policies (MWM 87%, psychosocial evaluation 75%). Revision procedures were covered in 79% (n = 48) of policies. Reimbursement of a second bariatric procedure for failure of weight loss was less frequently found (n = 41, 67%). A majority of private insurers still require a supervised medical weight management program prior to approval, and most will not cover adolescent bariatric surgery unless certain criteria, which are not supported by current evidence, are met.

Sections du résumé

BACKGROUND
Bariatric surgery remains underutilized at a national scale, and insurance company reimbursement is an important determinant of access to these procedures. We examined the current state of coverage criteria for bariatric surgery set by private insurance companies.
METHODS
We surveyed medical policies of the 64 highest market share health insurance providers in the USA. ASMBS guidelines and the CMS criteria for pre-bariatric evaluation were used to collect private insurer coverage criteria, which included procedures covered, age, BMI, co-morbidities, medical weight management program (MWM), psychosocial evaluation, and a center of excellence designation. We derive a comprehensive checklist for pre-bariatric patient evaluation.
RESULTS
Sixty-one companies (95%) had defined pre-authorization policies. All policies covered the RYGB, and 57 (93%) covered the LAGB or the SG. Procedures had coverage limited to center of excellence in 43% of policies (n = 26). A total of 92% required a BMI of 40 or above or of 35 or above with a co-morbidity; however, 43% (n = 23) of policies covering adolescents (n = 36) had a higher BMI requirement of 40 or above with a co-morbidity. Additional evaluation was required in the majority of policies (MWM 87%, psychosocial evaluation 75%). Revision procedures were covered in 79% (n = 48) of policies. Reimbursement of a second bariatric procedure for failure of weight loss was less frequently found (n = 41, 67%).
CONCLUSIONS
A majority of private insurers still require a supervised medical weight management program prior to approval, and most will not cover adolescent bariatric surgery unless certain criteria, which are not supported by current evidence, are met.

Identifiants

pubmed: 31749107
doi: 10.1007/s11695-019-04243-2
pii: 10.1007/s11695-019-04243-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-713

Références

Surg Obes Relat Dis. 2010 Jan-Feb;6(1):8-15
pubmed: 19782647
Surg Obes Relat Dis. 2017 May;13(5):871-876
pubmed: 28233687
Surg Endosc. 2015 Sep;29(9):2794-9
pubmed: 25492453
J Intern Med. 2013 Mar;273(3):219-34
pubmed: 23163728
Med Care. 1981 Feb;19(2):127-40
pubmed: 7206846
Clin Obes. 2015 Dec;5(6):312-24
pubmed: 26541244
Obesity (Silver Spring). 2006 Mar;14 Suppl 2:70S-76S
pubmed: 16648597
Obesity (Silver Spring). 2013 Mar;21 Suppl 1:S1-27
pubmed: 23529939
Surg Obes Relat Dis. 2010 Jul-Aug;6(4):391-8
pubmed: 20655021
Med Care. 2018 Jul;56(7):583-588
pubmed: 29762271
JAMA Surg. 2015 Jul;150(7):644-8
pubmed: 25993654
Surg Obes Relat Dis. 2016 Mar-Apr;12(3):496-499
pubmed: 26775043
Obes Surg. 2018 Jun;28(6):1711-1723
pubmed: 29468360
Ann Surg. 2008 Nov;248(5):763-76
pubmed: 18948803
JAMA. 2012 Sep 19;308(11):1122-31
pubmed: 22990271
Surg Obes Relat Dis. 2018 May;14(5):636-639
pubmed: 29776491
Surg Obes Relat Dis. 2018 May;14(5):631-636
pubmed: 29454535
J Pediatr Surg. 2013 Dec;48(12):2401-7
pubmed: 24314178
JAMA. 2013 Dec 11;310(22):2416-25
pubmed: 24189773
Qual Health Res. 2015 Jan;25(1):51-61
pubmed: 25185162
Surg Obes Relat Dis. 2018 May;14(5):623-630
pubmed: 29525261
Surg Obes Relat Dis. 2011 May-Jun;7(3):257-60
pubmed: 21621163
Surg Obes Relat Dis. 2016 Jun;12(5):955-9
pubmed: 27523728
Obes Surg. 2015 May;25(5):860-78
pubmed: 25697125
Surg Obes Relat Dis. 2018 Sep;14(9):1221-1232
pubmed: 30154033
Obes Surg. 2018 Jan;28(1):44-51
pubmed: 28667512
Surg Obes Relat Dis. 2011 Nov-Dec;7(6):760-7; discussion 767
pubmed: 21978748
Obes Surg. 2017 Jan;27(1):208-214
pubmed: 27761723
Surg Obes Relat Dis. 2017 Sep;13(9):1619-1627
pubmed: 28499887
Surg Obes Relat Dis. 2019 Jan;15(1):146-151
pubmed: 30425002
Surg Obes Relat Dis. 2018 Aug;14(8):1071-1087
pubmed: 30061070
Surg Obes Relat Dis. 2016 Jun;12(5):1045-1050
pubmed: 27260649
Surg Obes Relat Dis. 2016 Jul;12(6):1163-70
pubmed: 27425840
Surg Obes Relat Dis. 2018 Jul;14(7):882-901
pubmed: 30077361
Obes Rev. 2013 Aug;14(8):634-44
pubmed: 23577666
Ann Surg. 2011 Dec;254(6):860-5
pubmed: 21975317
Surg Obes Relat Dis. 2014 Sep-Oct;10(5):767-73
pubmed: 25002327

Auteurs

Selim G Gebran (SG)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Brooks Knighton (B)

University of Maryland School of Medicine, Baltimore, MD, USA.

Ledibabari M Ngaage (LM)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

John A Rose (JA)

Department of Plastic & Reconstructive Surgery, The Johns Hopkins University, Baltimore, MD, USA.

Michael P Grant (MP)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Fan Liang (F)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Arthur J Nam (AJ)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Stephen M Kavic (SM)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Mark D Kligman (MD)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Yvonne M Rasko (YM)

Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA. yrasko@som.umaryland.edu.
Division of Plastic Surgery, Department of Surgery, University of Maryland Medical Center, 22 S Greene St, Baltimore, MD, 21230, USA. yrasko@som.umaryland.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH